Sino Biopharmaceutical Ltd 2025 SR
The report highlights Sino Biopharmaceutical Limited's ESG achievements in 2025, marking the launch of its second three-year ESG roadmap. The company successfully integrated AI across its R&D, manufacturing, and corporate functions, accelerating drug discovery and clinical trials. Notably, Sino Biopharmaceutical became one of the first in China's pharmaceutical industry to publish a carbon neutrality roadmap, achieving a simultaneous reduction in total greenhouse gas emissions and intensity for the first time. The company also expanded healthcare access, with products now spanning 28 countries and regions, and established the Sino Biopharmaceutical Charity Foundation to coordinate its philanthropic efforts.
Company: Sino Biopharmaceutical Ltd
Sector: Health Care
Country: Hong Kong
Year: 2025
Type: SR
Pages: 100
Sino Biopharmaceutical Ltd
Environmental, Social And Governance Report
The report highlights Sino Biopharmaceutical Limited's ESG achievements in 2025, marking the launch of its second three-year ESG roadmap. The company successfully integrated AI across its R&D, manufacturing, and corporate functions, accelerating drug discovery and clinical trials. Notably, Sino Biopharmaceutical became one of the first in China's pharmaceutical industry to publish a carbon neutrality roadmap, achieving a simultaneous reduction in total greenhouse gas emissions and intensity for the first time. The company also expanded healthcare access, with products now spanning 28 countries and regions, and established the Sino Biopharmaceutical Charity Foundation to coordinate its philanthropic efforts.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees